V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016699 | 270014511 | 1.8 | 64 | Not known (9) | 2014-04-12 | 2014-04-24 | Fluorouricil + Folonic Acid (MdG) | 02 | null | 270016538 | FLUOROURACIL |
| 270016700 | 270009644 | null | null | Curative (C) | null | 2016-02-08 | null | null | null | 270016540 | NOT MATCHED |
| 270016701 | 270016999 | 1.72 | 76 | Curative (C) | 2016-03-18 | 2016-03-24 | CHOP R - 21 days | 02 | Y | 270016542 | CHOP R |
| 270016702 | 270009646 | 1.6 | 95.4 | Curative (C) | 2017-11-11 | 2017-11-19 | CHOP R - 21 days | 02 | null | 270016545 | CHOP R |
| 270016703 | 270014514 | 1.84 | null | Palliative (P) | null | 2017-05-11 | Capecitabine (14 day) + Irinotecan | null | null | 270016559 | CAPECITABINE + IRINOTECAN |
| 270016704 | 270019237 | 1.8 | 83 | Curative (C) | 2013-09-24 | 2014-02-19 | Capecitabine 42days + RT | 02 | N | 270016570 | CAPECITABINE + RT |
| 270016705 | 270017003 | 1.73 | 55.4 | null | 2018-08-02 | 2018-08-02 | HLH Ind W1 &2 Etop/Dexamethasone | 02 | N | 270016578 | NOT MATCHED |
| 270016706 | 270009655 | 1.6 | 70 | Curative (C) | 2016-10-28 | 2017-02-24 | Escalated BEACOP Dac | N | N | 270016580 | NOT MATCHED |
| 270016707 | 270014519 | 1.63 | 65.2 | Curative (C) | 2017-05-01 | 2017-05-08 | ATG + Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | N | N | 270016581 | NOT MATCHED |
| 270016708 | 270009656 | 1.75 | 95.7 | Palliative (P) | null | 2017-11-11 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016596 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016709 | 270009658 | 1.65 | 68 | Not known (9) | 2014-02-02 | 2014-02-13 | Fluorouricil + Folonic Acid (MdG) | 99 | null | 270016598 | FLUOROURACIL |
| 270016710 | 270009658 | 1.55 | 81.2 | Palliative (P) | 2015-02-22 | 2015-03-04 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016598 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016711 | 270019239 | 1.57 | 64 | Curative (C) | 2017-11-27 | 2017-11-28 | CHOP R | 02 | Y | 270016607 | CHOP R |
| 270016712 | 270009663 | 1.58 | 97 | Disease modification (D) | 2016-05-17 | 2016-05-17 | ATG + Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | 2 | N | 270016608 | NOT MATCHED |
| 270016713 | 270009664 | 1.62 | 67 | Neo-adjuvant (N) | null | 2018-09-17 | Trifluridine + Tipiracil | null | null | 270016614 | TRIFLURIDINE + TIPIRACIL |
| 270016714 | 270014526 | 1.66 | 57.4 | Palliative (P) | 2018-08-10 | 2018-08-16 | DHAP | 02 | N | 270016617 | DHAP |
| 270016715 | 270014527 | null | null | Palliative (P) | 2015-07-02 | 2015-07-10 | CHLVPP | 02 | N | 270016619 | CHLVPP |
| 270016716 | 270009671 | 1.77 | 73.2 | Adjuvant (A) | 2018-11-04 | 2018-11-04 | Cetuximab + Radiotherapy Maint | 2 | N | 270016621 | CETUXIMAB + RT |
| 270016717 | 270009674 | null | 71 | Neo-adjuvant (N) | 2015-05-23 | 2015-06-07 | Bevacizumab + Oxaliplatin +MdG | null | null | 270016623 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016718 | 270009676 | 1.73 | 71.2 | Palliative (P) | 2016-09-10 | 2016-09-17 | CHLVPP | N | Y | 270016635 | CHLVPP |
| 270016719 | 270009678 | 1.65 | 67 | Curative (C) | 2018-09-21 | 2018-09-26 | CHLVPP | N | N | 270016640 | CHLVPP |
| 270016720 | 270017017 | 1.7 | null | Palliative (P) | 2016-11-04 | 2016-11-06 | Trifluridine + Tipiracil | null | null | 270016647 | TRIFLURIDINE + TIPIRACIL |
| 270016721 | 270014535 | 1.67 | null | Palliative (P) | 2016-06-24 | 2016-07-08 | Capecitabine (21 day) + Irinotecan | 02 | null | 270016648 | CAPECITABINE + IRINOTECAN |
| 270016722 | 270009682 | 1.52 | 64.9 | Palliative (P) | 2015-08-04 | 2017-03-14 | Trifluridine + Tipiracil | 02 | N | 270016654 | TRIFLURIDINE + TIPIRACIL |
| 270016723 | 270009683 | null | null | Adjuvant (A) | 2018-11-06 | 2018-11-07 | CAPECITABINE + IRINOTECAN | 02 | Y | 270016659 | CAPECITABINE + IRINOTECAN |
| 270016724 | 270009684 | 1.59 | 80 | Palliative (P) | 2016-03-30 | 2016-04-03 | CISPLATIN + FLUOROURACIL | 2 | N | 270016660 | CISPLATIN + FLUOROURACIL |
| 270016725 | 270014540 | 1.63 | 85.4 | Curative (C) | 2014-05-06 | 2014-05-10 | CHLVPP | N | N | 270016660 | CHLVPP |
| 270016726 | 270017021 | 0 | 88.4 | Palliative (P) | 2015-11-21 | 2016-02-26 | Fluorouricil + Folonic Acid (MdG) | N | N | 270016670 | FLUOROURACIL |
| 270016727 | 270009691 | 1.83 | 59.9 | Curative (C) | 2017-07-17 | 2017-07-20 | Capecitabine 42days + RT | N | N | 270016676 | CAPECITABINE + RT |
| 270016728 | 270009693 | 1.75 | 93 | Palliative (P) | 2014-11-12 | 2014-11-13 | HD Lymph Pred EuroNet-PHL-LP1 CVP | 2 | N | 270016682 | NOT MATCHED |
| 270016729 | 270009697 | 1.71 | null | Curative (C) | 2014-08-20 | 2014-08-25 | CHOP R - 21 days | N | N | 270016685 | CHOP R |
| 270016730 | 270009698 | 1.47 | 88 | Adjuvant (A) | 2016-09-26 | 2016-10-09 | GEM-P | N | N | 270016697 | GEMCITABINE + PACLITAXEL |
| 270016731 | 270009701 | null | 57.8 | Adjuvant (A) | null | 2013-11-27 | Bendamustine +/- Prednisolone | null | null | 270016705 | BENDAMUSTINE |
| 270016732 | 270014548 | null | null | Curative (C) | 2015-02-05 | 2015-02-05 | Irinotecan 14day | 02 | N | 270016708 | IRINOTECAN |
| 270016733 | 270009706 | 1.77 | 0 | Curative (C) | 2018-02-25 | 2018-03-02 | GEM-P | 2 | N | 270016709 | GEMCITABINE + PACLITAXEL |
| 270016734 | 270009709 | 1.76 | 51 | Adjuvant (A) | 2016-12-12 | 2016-12-12 | Irinotecan 14day | 02 | N | 270016717 | IRINOTECAN |
| 270016735 | 270009711 | 1.7 | 93 | Adjuvant (A) | 2014-12-28 | 2014-12-28 | Oxaliplatin + Raltitrexed | 2 | N | 270016728 | BEAM + ALEMTUZUMAB |
| 270016736 | 270009712 | 1.62 | 81.6 | Not known (9) | 2015-04-28 | 2015-11-11 | IVE | 2 | N | 270016733 | IVE |
| 270016737 | 270009714 | null | 68.1 | Curative (C) | 2018-01-29 | 2018-01-31 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | 270016734 | CISPLATIN |
| 270016738 | 270009714 | 1.71 | 54.2 | Curative (C) | 2019-02-07 | 2019-02-11 | Vinblastine weekly | N | N | 270016734 | BEVACIZUMAB |
| 270016739 | 270009716 | 1.66 | 73 | Adjuvant (A) | 2015-02-02 | 2015-05-09 | BENDAMUSTINE | N | N | 270016740 | BENDAMUSTINE |
| 270016740 | 270017030 | 1.7 | 68.8 | Adjuvant (A) | 2018-07-13 | 2018-08-08 | Panitumumab | 02 | N | 270016742 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016741 | 270009717 | 0 | 96.4 | Adjuvant (A) | 2015-02-19 | 2015-10-03 | VEPEMB | N | N | 270016750 | BEVACIZUMAB |
| 270016742 | 270009721 | 1.89 | 66.9 | Adjuvant (A) | 2015-11-14 | 2015-12-02 | VEPEMB | N | N | 270016757 | BEAM + ALEMTUZUMAB |
| 270016743 | 270009723 | 1.58 | 60.2 | Not known (9) | 2013-09-19 | 2013-09-28 | BEAM + Alemtuzumab Allo SCT | 02 | N | 270016761 | CARBOPLATIN |
| 270016744 | 270009728 | 1.72 | 56 | Not known (9) | 2018-02-19 | 2018-04-23 | Bevacizumab | N | N | 270016770 | NIVOLUMAB |
| 270016745 | 270017035 | 1.6 | 54 | Curative (C) | 2015-02-28 | 2015-06-11 | BEAM + Alemtuzumab Allo SCT | N | N | 270016776 | VINBLASTINE |
| 270016746 | 270009733 | 1.81 | 0 | Disease modification (D) | 2016-12-01 | 2016-12-21 | Cyclophosphamide High Dose | 01 | Y | 270016777 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270016747 | 270009736 | null | 100.7 | Adjuvant (A) | 2017-02-28 | 2017-03-04 | Panitumumab | N | null | 270016781 | BEVACIZUMAB |
| 270016748 | 270009739 | 1.79 | 58.2 | Neo-adjuvant (N) | null | 2014-09-02 | NIVOLUMAB | N | null | 270016783 | CISPLATIN + GEMCITABINE |